NCT06225596 2026-04-15
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
BicycleTx Limited
Phase 2/3 Active not recruiting
BicycleTx Limited
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Medicine Invention Design, Inc
Eli Lilly and Company
Centre hospitalier de l'Université de Montréal (CHUM)
University of Vermont
Sir Mortimer B. Davis - Jewish General Hospital
Medical Research Council
Columbia University